Federal judges denied a Trump administration proposal to deny green cards to immigrants requiring public benefits; researchers aim to develop a test to assess hereditary diabetes risk; vaping-related deaths rise to 29 nationwide.
Federal judges in New York, California, and Washington state partially blocked the implementation of a rule proposed by the Trump administration to disqualify immigrants from receiving green cards if they use public benefits or are likely to require them, according to The Washington Post. The administration's proposal is part of a broader effort to shrink the number of immigrants entering the country, and judges also denied redirecting billions in defense funds Congress had approved for other uses to erect hundreds of miles of steel barriers across the border with Mexico. The Trump administration is expected to appeal the ruling.A test developed at the University of Virginia utilizing dozens of gene variations related to type 1 diabetes (T1D), risk seeks to identify at-risk children to prevent serious complications and emergency visits, according to NPR. First a $7 test will identify those at greatest genetic risk of developing T1D; then, a $75 blood test that identifies troubling antibodies will be given periodically only to those at highest risk. Researchers have recruited 2000 children so far for the study, with 60 bearing a high genetic risk.Last Thursday, Indiana confirmed 2 more deaths attributed to e-cigarettes, bringing the number of vaping-related deaths to 29 nationwide, according to Reuters. US health officials in the FDA and CDC have stressed for the public to avoid using e-cigarettes until investigations into the mysterious lung illnesses associated to these devices have concluded. Reported symptoms of these illnesses include coughing, shortness of breath, chest pain, nausea, and diarrhea. Temporary bans on the sale of flavored e-cigarettes have already been imposed in New York, Michigan, and Rhode Island.
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Team-Based CINEMA Program Targets SDOH and Precision Care in Diabetes
December 20th 2024Ian Neeland, MD, discusses the CINEMA program's impact on addressing social determinants of health (SDOH) in Ohio and the importance of precision risk tests to reduce cardiovascular metabolic disease risk.
Read More